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OBJECTIVES The aim of this study was to determine the significance of peripheral monocytosis in clinical
outcome after reperfused acute myocardial infarction (AMI), especially relating to post-
infarct left ventricular (LV) remodeling.
BACKGROUND Peripheral monocytosis occurs two to three days after AMI, reflecting infiltration of
monocytes and macrophages into the necrotic myocardium. However, the prognostic
significance of peripheral monocytosis after AMI remains to be determined.
METHODS A total of 149 patients with first Q-wave AMI were studied. White blood cell (WBC) count,
percentage of monocytes and serum C-reactive protein level were measured every 24 h for
four days after the onset of AMI. We assessed association between peripheral monocytosis
and prognosis including pump failure, LV aneurysm and long-term outcome after AMI.
RESULTS Patients with pump failure (p  0.0001) or LV aneurysm (p  0.005) had higher peak
monocyte counts than those without these complications. Predischarge left ventriculography
revealed that peak monocyte count was positively correlated with LV end-diastolic volume
(p 0.024) and negatively correlated with ejection fraction (p 0.023). Multivariate analyses
showed that peak monocyte count 900/mm3 was an independent determinant of pump
failure (relative risk [RR] 9.83, p  0.0001), LV aneurysm (RR 4.78, p  0.046) and cardiac
events (RR 6.30, p  0.0001), including readmission for heart failure, recurrent myocardial
infarction and cardiac deaths, including sudden deaths.
CONCLUSIONS Peripheral monocytosis is associated with LV dysfunction and LV aneurysm, suggesting a
possible role of monocytes in the development of LV remodeling after reperfused
AMI. (J Am Coll Cardiol 2002;39:241–6) © 2002 by the American College of Cardiology
Left ventricular (LV) remodeling after acute myocardial
infarction (AMI) is the process of infarct expansion fol-
lowed by progressive LV dilation and is associated with an
adverse clinical outcome (1,2). Defective infarct healing, as
well as large infarct size and wall stress, is a major determi-
nant of infarct expansion (3). The vulnerable myocardium,
which consists of necrotic myocardium and inflammatory
cells, is susceptible to wall stress, resulting in infarct expan-
sion. Ventricular aneurysm or subacute cardiac rupture is
one of the resultant features of infarct expansion (4,5). We
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have reported that a marked elevation of serum C-reactive
protein (CRP) level is associated with subacute cardiac
rupture, LV aneurysm, and an adverse long-term outcome
after AMI, suggesting an important role of inflammatory
response in infarct expansion and LV remodeling (6).
However, the mechanism of the phenomenon has not been
fully elucidated. C-reactive protein is produced in the liver
by stimulation of monocyte-related cytokines, such as
interleukin-1, interleukin-6 (IL-6) and tumor necrosis
factor-alpha. Ikeda et al. reported (7) that plasma IL-6 level,
which is predominantly secreted from monocytes and mac-
rophages, correlated well with serum CRP level in patients
with AMI. These findings suggest that monocytes may be
related to the process of infarct healing and LV remodeling.
After AMI, the resident macrophages in infarcts are
activated and marginating monocytes localized close to the
endothelium migrate into the necrotic myocardium through
interaction with adhesion molecules. The macrophages and
monocytes synthesize and secrete humoral factors, including
a factor increasing monocytopoiesis, IL-6, macrophage-
colony stimulating factor (M-CSF) and monocyte chemoat-
tractant protein-1 (MCP-1) (8,9). These monocyte-related
cytokines induce peripheral monocytosis and infiltration of
monocytes into the necrotic myocardium. A previous report
(10) showed that peripheral monocyte count and monocyte-
related cytokines were increased in patients with AMI. How-
ever, association between peripheral monocyte count and
short- or long-term prognosis has not been examined. If the
recruitment of circulating monocytes to the injured myocar-
dium plays an important role in the infarct healing process,
peripheral monocytosis may be related to LV remodeling after
AMI. The purposes of this study were to assess prognostic
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significance of peripheral monocytosis after reperfused AMI,
especially in relation to post-infarct LV remodeling.
METHODS
Study population. We examined 189 consecutive patients
with first Q-wave AMI treated with primary percutaneous
transluminal coronary angioplasty (PTCA). All patients
were admitted to Keio University Hospital within 24 h
between January 1994 and December 1999 and were per-
formed successful reperfusion (final Thrombolysis in Myo-
cardial Infarction flow grade 3 in the infarct-related coro-
nary artery without any residual stenosis). A diagnosis of
Q-wave AMI was made as previously described (6). We
excluded patients in whom the time elapsed from onset to
admission was greater than 24 h (24 patients) and those who
died before determination of the peak monocyte count (six
patients). Patients with collagen disease, advanced liver
disease, renal failure, malignancy or any infectious disease
were also excluded (seven patients). Finally, 149 patients
were included in this study.
Study protocol. Total and differential counts of leukocytes
were measured by an automated hematology analyzer (Sys-
mex SE-9000, Toa Medical Electronic, Inc., Kobe, Japan)
on admission and every 24 h for at least four days. Serum
samples were stored at 70°C and were later analyzed to
determine creatine kinase (CK) and CRP levels. C-reactive
protein levels were measured by latex photometric immu-
noassay (6). The following data were obtained: age; gender;
history of preinfarction angina; coronary risk factors includ-
ing cigarette smoking, hypertension, diabetes mellitus and
hypercholesterolemia; infarct site; use of stent as reperfusion
therapy; concomitant medications before and after hospital-
ization including beta-blockers and angiotensin-converting
enzyme (ACE) inhibitors and in-hospital complications as
previously described (11). In-hospital complications in-
cluded pump failure (a grade of class 2 or greater according
to Killip’s classification or subset II or greater according to
Forrester’s classification), recurrent myocardial infarction,
malignant ventricular arrhythmia (sustained ventricular
tachycardia or ventricular fibrillation) and cardiac death.
Follow-up data, including the history of readmission for
heart failure, recurrent myocardial infarction and cardiac
deaths, including sudden deaths, were obtained through
direct contact at an outpatient clinic in patients who
survived the AMI. The coronary angiograms and left
ventriculograms were analyzed by two independent angiog-
raphers without knowledge of the patient’s background.
Global LV ejection fraction and LV end-diastolic volume
were estimated from the right anterior oblique projection of
contrast left ventriculography during convalescence. Left
ventricular aneurysm was assessed from both the right and
left anterior oblique views as previously described (12). In 20
patients with first anterior AMI among the present popu-
lation, we measured plasma brain natriuretic peptide (BNP)
levels seven days after the onset. The study protocol was in
agreement with the guidelines of the ethics committee of
our institution.
Statistical analyses. Continuous data are expressed as the
mean value  SD. Comparison between two groups was
performed by using the unpaired t test or nonparametric
means test for continuous variables and by using the
chi-square test for categorical variables. Multiple logistic
regression analysis was used to assess the effect of various
factors on pump failure or development of LV aneurysm.
Twelve variables, including those with p values 0.10 by
univariate analyses, were further assessed by multiple logistic
regression analysis. Long-term cardiac event-free survival
was estimated using Kaplan-Meier curves and the log-rank
(Mantel-Cox) test to assess the significance of differences
according to the presence or absence of peripheral mono-
cytosis. Long-term cardiac events after the onset of AMI
were assessed by Cox proportional hazards model. To
determine cut-off points of the peak monocyte count as
predictors of pump failure, LV aneurysm and long-term
cardiac events, receiver operating characteristic (ROC) anal-
yses were performed. A p value 0.05 was considered
statistically significant. All statistical analyses were per-
formed using Statview 5.0 software (SAS Institute Inc.,
Cary, North Carolina).
RESULTS
Patient characteristics. For the entire study population,
the mean age was 64  12 years (range 29 to 93). Mean
interval from the onset of AMI to arrival at hospital was 5
5 h. The mean monocyte count on admission was 456 
289/mm3 and peak monocyte count was 711  292/mm3.
The mean time from the onset of AMI to the peak of
monocyte count was 2  1 days. Peak monocyte count did
not significantly differ according to patient characteristics
(Table 1).
Relationship between peak CK and CRP levels and peak
monocyte count. Peak monocyte count showed a signifi-
cant positive correlation with peak CK and CRP level (r2 
0.076, p  0.0008 and r2  0.28, p  0.0001, respectively),
although the correlation between peak monocyte count and
Abbreviations and Acronyms
ACE  angiotensin-converting enzyme
AMI  acute myocardial infarction
BNP  brain natriuretic peptide
CI  confidence interval
CK  creatine kinase
CRP  C-reactive protein
IL-6  interleukin-6
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MCP-1  monocyte chemoattractant protein-1
M-CSF  macrophage-colony stimulating factor
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RR  relative risk
WBC  white blood cell
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peak CK level was not close as that between peak monocyte
count and peak CRP level.
In-hospital complications and peak monocyte count.
Peak monocyte counts were higher in patients with pump
failure than in those without pump failure (941  348 vs.
605 196/mm3, p 0.0001). Patients with the presence of
LV aneurysm were associated with higher peak monocyte
counts than those with the absence of LV aneurysm (861 
402 vs. 682 256/mm3, p 0.005). Peak monocyte counts
were also higher in patients with malignant ventricular
arrhythmias than in those without these complications
(788  334 vs. 677  265/mm3, p  0.032).
Coronary angiographic and left ventriculographic find-
ings. Primary PTCA was performed in all patients at a
mean of 6  6 h after the onset of AMI. Peak monocyte
count was not different between patients with and without
multivessel coronary artery disease (706  281 vs. 704 
292/mm3, p  0.97). There was no difference in peak
monocyte count between patients with and without stent
implantation (714  303 vs. 698  263/mm3, p  0.93).
Left ventriculography was performed in 105 patients (70%)
during convalescence, a mean of 18  10 days after the
onset of AMI. Peak monocyte count was positively corre-
lated with LV end-diastolic volume (p  0.024) and
negatively correlated with LV ejection fraction (p  0.023).
Long-term prognosis. Of the 149 patients, 93% (n 138)
were followed for more than 12 months. Mean follow-up
period was 33  21 (range one to 78) months. Peak
monocyte counts were higher in patients who were read-
mitted for heart failure during the follow-up period after
AMI than in those without heart failure (900  420 vs.
671  250/mm3, p  0.0036). In patients who suffered
cardiac deaths, including sudden deaths, during in-hospital
course and the follow-up period after AMI, peak monocyte
counts were higher than in survivors (904  210 vs. 696 
284/mm3, p  0.048). Peak monocyte counts were higher
in patients with cardiac events, including readmission for
heart failure, recurrent myocardial infarction and cardiac
deaths, including sudden deaths, than in those without
these events (881  445 vs. 656  239/mm3, p  0.0074).
Determinants of pump failure, LV aneurysm and long-
term cardiac events. Cut-off points of peak monocyte
count for pump failure, LV aneurysm and long-term cardiac
events, determined by ROC analysis, were 881/mm3, 851/
mm3 and 865/mm3, respectively. Therefore, we used 900/
mm3 as a cut-off point for the analyses in clinical usefulness.
The cut-off point for pump failure, LV aneurysm and
long-term cardiac events yielded sensitivities of 70%, 60%
and 75% and specificities of 80%, 73% and 81%, respec-
tively.
Predictive factors for pump failure and LV aneurysm.
Univariate significant predictors of pump failure were older
age (70 years), peak white blood cell (WBC) count
12,000/mm3, peak monocyte count 900/mm3, peak CK
level 3,000 IU/l and use of beta-blockers after hospital-
ization. Those of LV aneurysm were anterior infarction,
peak monocyte count 900/mm3 and peak CK level
3,000 IU/l (Table 2). Multiple logistic regression analysis
showed that peak monocyte count 900/mm3 was an
independent predictor of pump failure (relative risk [RR]
9.83, 95% confidence interval [CI] 3.29 to 29.40, p 
0.0001), whereas peak WBC count12,000/mm3 and peak
CK level 3,000 IU/l were not (Table 3). In the same
analysis, peak monocyte count 900/mm3 was also an
independent predictor of LV aneurysm (RR 4.78, 95% CI
Table 1. Patient Characteristics and Peak Monocyte Counts
Peak Monocyte Count (/mm3)
p
ValuePresent Absent
Age 70 years 787  327 (55) 692  292 (94) NS
Male gender 743  311 (127) 610  257 (22) NS
Cigarette smoking 760  311 (79) 690  302 (70) NS
Hypertension 727  332 (94) 726  263 (55) NS
Diabetes mellitus 736  327 (69) 719  290 (80) NS
Hypercholesterolemia 687  288 (70) 765  322 (79) NS
Anterior infarction 760  344 (62) 667  228 (87) NS
Preinfarction angina 703  296 (72) 749  318 (77) NS
ACE inhibitors 699  266 (114) 699  299 (35) NS
Beta-blockers 727  305 (91) 660  268 (58) NS
Stent use 714  303 (77) 698  263 (72) NS
Data are presented as the mean value  SD or number of patients.
ACE  angiotensin-converting enzyme; NS  not significant.









Age 70 years (n  55) 29 (53) 0.0035 13 (23) 0.1619
Male gender (n  127) 46 (36) 0.7930 22 (17) 0.8026
Cigarette smoking (n  79) 27 (34) 0.6437 14 (18) 0.7765
Diabetes mellitus (n  69) 25 (36) 0.9295 14 (20) 0.3758
Hypercholesterolemia (n  70) 21 (30) 0.1541 11 (16) 0.6641
Anterior infarction (n  62) 23 (37) 0.6026 19 (31)  0.0001
Peak WBC count 12,000/mm3 (n  77) 35 (45) 0.0139 16 (21) 0.2423
Peak monocyte count 900/mm3 (n  43) 27 (63)  0.0001 17 (40) 0.0039
Peak CK level 3,000 IU/l (n  50) 28 (56) 0.0003 18 (35)  0.0001
ACE inhibitors (n  114) 35 (31) 0.2261 23 (20) 0.2391
Beta-blockers (n  91) 27 (30) 0.0343 17 (19) 0.8465
Stent use (n  77) 23 (30) 0.5449 14 (18) 0.1844
ACE  angiotensin-converting enzyme; CK  creatine kinase; LV  left ventricular; WBC  white blood cell.
243JACC Vol. 39, No. 2, 2002 Maekawa et al.
January 16, 2002:241–6 Monocytosis After Acute Myocardial Infarction
1.03 to 22.19, p  0.046) as well as anterior infarction and
peak CK level 3,000 IU/l (Table 4).
Long-term cardiac event-free survival and predictive
factor of cardiac events. Kaplan-Meier curves and the
log-rank test revealed that the peak monocyte count 900/
mm3 was associated with a higher incidence of cardiac
events during the follow-up period (Fig. 1). Cox propor-
tional hazards analysis revealed that peak monocyte count
900/mm3 was the sole independent predictor of the
cardiac events among the variables (Table 5).
Substudy for plasma BNP levels. Plasma BNP levels
seven days after the onset of anterior AMI were higher in
patients with peak monocyte count 900/mm3 than those
with peak monocyte count 900/mm3 (301.7  70.9 vs.
123.4  91.6 pg/ml, p  0.0048), although peak CK levels
were not significantly different between the two groups
(3,850  2,933 vs. 2,777  2,531 IU/l, p  0.1522).
DISCUSSION
This study showed that the peak monocyte count had a
significant positive correlation with LV end-diastolic vol-
ume obtained from predischarge left ventriculography. Pa-
tients with pump failure or LV aneurysm had higher peak
monocyte counts than those without these complications.
Multivariate analyses showed that a peak monocyte count
900/mm3 was an independent determinant of pump
failure, LV aneurysm and long-term cardiac events, suggest-
ing a possible role of monocytes in the development of LV
remodeling after reperfused AMI.
Role of leukocytes in infarct healing. An association
between leukocytosis and the prognosis of patients with
AMI has been demonstrated by several investigators (13–
16). These studies examined large numbers of patients and
showed the relationship between initial WBC counts and
prognosis after AMI. Kyne et al. (17) reported that a higher
neutrophil percentage count (65%) on admission was an
independent predictor of pump failure. However, the WBC
and differential counts were not serially measured in these
studies. It might be difficult to assess exactly the extent of
inflammatory response by one-point measurements of
WBC count, because neutrophil count on admission could
be influenced by time from onset to arrival. Although
neutrophils are the first leukocytes to be found in damaged
tissue, they are removed from myocardial tissue after phago-
cytosing the debris. Therefore, neutrophils do not appear to
have a role in the subsequent events of infarct healing.
Monocytes and macrophages are other leukocytes involved
in infarct healing. As monocytes migrate from capillaries
into the extravascular space, they are transformed into
macrophages. At two to three days, macrophages begin to
outnumber neutrophils and play a major role in tissue repair
(18,19). Macrophages phagocytose necrotic tissue and se-
Figure 1. Kaplan-Meier curves and log-rank test revealed that a higher
peak monocyte count was associated with lower cardiac event-free survival
during the follow-up period after acute myocardial infarction. Cardiac
events were defined as readmission for heart failure, recurrent myocardial
infarction and cardiac deaths, including sudden deaths. p  0.0001.
Table 5. Univariate and Multivariate Cox Proportional Hazards








Age 70 years 0.02 1.16 0.52–2.55 0.72
Cigarette smoking 0.77 1.81 0.83–3.97 0.14
Anterior infarction 0.06 1.56 0.72–3.38 0.26
Peak WBC count
12,000 /mm3
0.01 1.11 0.46–2.67 0.82
Peak monocyte count
900 /mm3
 0.0001 6.30 2.75–14.43  0.0001
Peak CK level
3,000 IU/l
0.004 1.99 0.89–4.43 0.09
ACE inhibitors 0.75 0.42 0.15–1.15 0.09
Beta-blockers 0.06 0.71 0.35–1.45 0.35
Cardiac events included readmission for heart failure, recurrent myocardial infarction
and cardiac deaths including sudden deaths.
ACE angiotensin-converting enzyme; CI confidence interval; CK creatine
kinase; WBC  white blood cell.






Age 70 years 2.93 1.18–7.25 0.02
Peak WBC count 12,000 /mm3 1.41 0.56–3.55 0.46
Peak monocyte count 900 /mm3 9.83 3.29–29.40  0.0001
Peak CK level 3,000 IU/l 2.51 1.02–6.18 0.05
Beta blockers 0.35 0.14–0.86 0.02
CI  confidence interval; CK  creatine kinase; WBC  white blood cell.






Peak monocyte count 900 /mm3 4.78 1.03–22.19 0.046
Peak CK level 3,000 IU/l 6.91 2.13–22.36 0.003
Anterior infarction 10.45 2.17–50.25 0.001
CI  confidence interval; CK  creatine kinase; LV  left ventricular.
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crete several cytokines, which stimulate fibroblast prolifer-
ation, collagen production and other healing process. These
monocyte-related cytokines promote peripheral monocyto-
sis and infiltration of peripheral monocytes into the necrotic
myocardium in a positive feedback manner. Although the
acute phase of inflammation is a necessary response for the
healing process, persistent and excessive activation could be
deleterious to the host.
Relationship between monocytes and LV remodeling
after AMI. In the present study, peak monocyte count was
not closely correlated with peak CK level. Meisel et al. (20)
showed that peak monocyte count had a significant corre-
lation with peak CK level (r  0.39, p  0.001), represent-
ing the extent of myocardial necrosis. However, in their
study, there was no precise information regarding the use
of revascularization therapy. In addition, the average time
to peak CK level in their study was greater (33  14 h)
than that in our present study (18  12 h). It is possible
that the washout effect of CK from reperfused myocar-
dium may be in part responsible for the weak correlation
in the present study. Alternatively, the inflammatory
response may vary among patients with AMI and may be one
of the factors that affect LV remodeling after AMI. In fact,
multivariate analyses revealed that a peak monocyte count
900/mm3 was an independent predictor of pump failure and
LV aneurysm among variables including peak CK levels
3,000 IU/l.
Plasma BNP is a clinically useful marker to predict
late-phase LV function after AMI. Its level seven days after
AMI is known to be correlated with increase in LV
end-diastolic volume, implicating the extent of post-infarct
LV remodeling (21). We showed the significant relation-
ship between peak monocyte counts and plasma BNP levels
seven days after the onset of anterior AMI. It is possible that
peripheral monocytosis is related to infarct healing and
thereby reflects LV remodeling.
Study limitations. First, we did not perform functional
analysis of peripheral monocytes. Measurements of
monocyte-related cytokines, such as IL-6, M-CSF and
MCP-1, will be needed to assess the monocyte activation
following AMI. Second, there is no direct evidence in the
present study to show that the increased peripheral mono-
cytes infiltrate into the necrotic myocardium and contribute
to the infarct healing process, although previous pathologic
study showed that peripheral monocytosis precedes increase
in number of monocytes and macrophages in the infarct
tissue (18). Third, we could not precisely evaluate the effect
of ACE inhibitors or beta-blockers on peripheral monocy-
tosis, because the dose and the time from onset to initial
administration of these drugs were variable among the
patients.
Conclusions. The present study demonstrated that periph-
eral monocytosis is associated with pump failure, LV aneu-
rysm and long-term outcome after reperfused AMI, sug-
gesting a possible role of monocytes in the development of
post-infarct LV remodeling. Further detailed studies are
required to determine whether these findings would be
identified in large clinical trials.
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